A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

Bengaluru-based biotechnology startup CrisprBits Private Limited has raised USD 3 Million through founders, angels & family ...

CrisprBits has secured $3 Mn (INR 26.8 Cr) in a pre-Series A funding round led by Spectrum Impact and Rajendra Gogri's family ...

Shares of Intellia Therapeutics NTLA have witnessed a sharp decline in the past month, primarily due to a regulatory setback ...

A breakthrough study has just supercharged Fusarium venenatum (the fungus used in mycoprotein products like Quorn), turning ...

CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing ...

The new GE technology — for which the Indian Council of Agricultural Research (ICAR) has recently been granted a patent — ...

Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned ...

Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...

Detailed price information for Avant Technologies Inc (AVAI) from The Globe and Mail including charting and trades.

How Cell And Gene Therapy Could Redefine Chronic Disease Treatment. Five companies are racing to bring CRISPR-based and ...

The U.S. Cellular Reprogramming Tools Market is entering a high-growth decade, projected to expand from USD 446.8 million in ...